Possibility of Using NO Modulators for Pharmacocorrection of Endothelial Dysfunction After Prenatal Hypoxia
И. Ф. Беленичев(Zaporizhzhia State Medical and Pharmaceutical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Oleh Yadlovskyi(Institute of Pharmacology and Toxicology of the National Academy of Medical Sciences of Ukraine), Nina Bukhtiyarova(Zaporizhzhia State Medical and Pharmaceutical University), Olena Popazova(Zaporizhzhia State Medical and Pharmaceutical University), Valentyn Oksenych(University of Bergen), Victor Ryzhenko(Zaporizhzhia State Medical and Pharmaceutical University), С. В. Павлов(Zaporizhzhia State Medical and Pharmaceutical University)
Cited by 5
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48